Advanced Search

Technical Analysis for KNSA - Kiniksa Pharmaceuticals, Ltd.

Grade Last Price % Change Price Change
C 21.985 3.85% 0.82
KNSA closed down 3.29 percent on Tuesday, March 2, 2021, on 1.44 times normal volume.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down
Historical KNSA trend table...
Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 2.22%
Crossed Above 20 DMA Bullish -1.14%
50 DMA Support Bullish 5.20%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 5.20%
Doji - Bullish? Reversal 5.20%
Multiple of Ten Bullish Other 5.20%
Fell Below 20 DMA Bearish 3.94%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 3.94%
Outside Day Range Expansion 3.94%
MACD Bearish Signal Line Cross Bearish -1.05%
Older End-of-Day Signals for KNSA ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High 16 minutes ago
10 DMA Resistance 16 minutes ago
Outside Day 16 minutes ago
20 DMA Resistance about 4 hours ago
Rose Above 20 DMA about 4 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators Basic chart:

Profile

Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Pharmaceutical Industry Diseases Medication Pharmacology

Is KNSA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Mar 2 Kiniksa Launches Patient Registry (RESONANCE) for Recurrent Pericarditis
Feb 28 Attention Biotech Investors: Mark Your Calendar For March PDUFA Dates
Feb 23 Kiniksa Pharmaceuticals EPS misses by $0.18
Feb 23 Kiniksa Reports Fourth Quarter and Full-Year 2020 Financial Results and Corporate and Pipeline Activity
Feb 17 3 Top Biotech Stocks With Major Catalysts Approaching
Jan 27 New Strong Sell Stocks for January 27th
Jan 11 Kiniksa Highlights Corporate Priorities and Expected 2021 Milestones
Jan 4 Kiniksa Pharmaceuticals to Present at 39th Annual J.P. Morgan Healthcare Conference
Dec 22 Kiniksa's antibody treatment shows clinical benefit in late-stage COVID-19 study
Dec 22 Kiniksa Announces Data from U.S. Investigator-Initiated Study of Mavrilimumab in Severe COVID-19 Pneumonia and Hyperinflammation
See more KNSA news...

Indicators

Indicator Value
52 Week High 28.67
52 Week Low 10.3
Average Volume 348,727
200-Day Moving Average 19.33
50-Day Moving Average 20.02
20-Day Moving Average 21.85
10-Day Moving Average 22.19
Average True Range 1.52
ADX 17.15
+DI 24.60
-DI 19.88
Chandelier Exit (Long, 3 ATRs ) 20.15
Chandelier Exit (Short, 3 ATRs ) 23.34
Upper Bollinger Band 23.93
Lower Bollinger Band 19.77
Percent B (%b) 0.34
BandWidth 19.03
MACD Line 0.44
MACD Signal Line 0.69
MACD Histogram -0.2529
Fundamentals Value
Market Cap 669.76 Million
Num Shares 31.6 Million
EPS -3.34
Price-to-Earnings (P/E) Ratio -6.34
Price-to-Sales 0.00
Price-to-Book 3.47
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 22.89
Resistance 3 (R3) 23.02 22.58 22.60
Resistance 2 (R2) 22.58 22.14 22.51 22.51
Resistance 1 (R1) 21.88 21.87 21.66 21.74 22.41
Pivot Point 21.44 21.44 21.33 21.37 21.44
Support 1 (S1) 20.73 21.00 20.51 20.60 19.93
Support 2 (S2) 20.29 20.73 20.22 19.83
Support 3 (S3) 19.59 20.29 19.74
Support 4 (S4) 19.45